Abstract
Background
Ecstasy use is associated with cognitive impairment, believed to result from damage to 5-HT axons. Neuroimaging techniques to investigate executive dysfunction in ecstasy users provide a more sensitive measure of cognitive impairment than behavioural indicators. The present study assessed executive access to semantic memory in ecstasy polydrug users and non-users.
Methods
Twenty ecstasy polydrug users and 20 non-user controls completed an oral variant of the Chicago Word Fluency Test (CWFT), whilst the haemodynamic response to the task was measured using functional near-infrared spectroscopy (fNIRS).
Results
There were no between-group differences in many background measures including measures of sleep and mood state (anxiety, arousal, hedonic tone). No behavioural differences were observed on the CWFT. However, there were significant differences in oxy-Hb level change at several voxels relating to the left dorsolateral prefrontal cortex (DLPFC) and right medial prefrontal cortex (PFC) during the CWFT, indicating increased cognitive effort in ecstasy users relative to controls. Regression analyses showed that frequency of ecstasy use, total lifetime dose and amount used in the last 30 days was significant predictors of oxy-Hb increase at several voxels after controlling for alcohol and cannabis use indices.
Conclusion
The results suggest that ecstasy users show increased activation in the PFC as a compensatory mechanism, to achieve equivalent performance to non-users. These findings are in agreement with much of the literature in the area which suggests that ecstasy may be a selective serotonin neurotoxin in humans.
Similar content being viewed by others
Notes
Due to small amounts of missing data on different optodes, MANOVA was not appropriate for this analysis.
References
Ayaz, H., Izzetoglu, M., Shewokis, P.A., & Onaral, B. (2010). Sliding-window motion artifact rejection for functional near-infrared spectroscopy. Conf Proc IEEE Eng Med Biol Soc 6567–6570
Ayaz H, Shewokis PA, Curtin A, Izzetoglu M, Izzetoglu K, Onaral B (2011) Using MazeSuite and functional near infrared spectroscopy to study learning in spatial navigation. J Vis Exp 56:e3443
Ayaz H, Cakir MP, Izzetoglu K, Curtin A, Shewokis PA, Bunce SC, Onaral B (2012) Monitoring expertise development during simulated UAV piloting tasks using optical brain imaging. IEEE Aerospace Conference, USA, pp 1–11
Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE (2003) Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clin Neuropsychol 17(4):446–459
Bedi G, Redman J (2008) Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds. Psychol Med 38(9):1319–1330
Bexis S, Docherty JR (2006) Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve α-adrenoceptors. Br J Pharmacol 147(8):926–934
Bhattachary S, Powell JH (2001) Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment. Psychol Med 31(4):647–658
Costafreda SG, Fu CHY, Lee L, Everitt B, Brammer MJ, David AS (2006) A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus. Hum Brain Mapp 27:799–810
Crime Survey of England and Wales (2013). Available at https://www.gov.uk/government/publications/drug-misuse-findings-from-the-2012-to-2013-csew. Accessed 9 June 2014
Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373–379
Curtis CE, D’Esposito (2003) Persistent activity in the prefrontal cortex during working memory. TRENDS Cogn Sci 7(9):415–423
Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL (2012) Evidence for chronically altered cortical serotonin function in human female recreational ecstasy (MDMA) polydrug users. Arch Gen Psychiatry 69(4):399–409
Ehlis A-C, Bähne CG, Jacob CP, Hermann MJ, Fallgatter AJ (2008) Reduced lateral prefrontal activation in adult patients with attention-deficit/hyperactivity disorder (ADHD) during a working memory task: a functional near-infrared spectroscopy (fNIRS) study. J Psychiatr Res 42(13):1060–1067
Firbank M, Okada E, Delpy DT (1998) A theoretical study of the signal contribution of regions of the adult head to near-infrared spectroscopy studies of visual evoked responses. Neuroimage 8:69–78
Fisk JE, Montgomery C (2009) Evidence for selective executive function deficits in ecstasy/polydrug users. J Psychopharmacol 23(1):40–50
Fisk JE, Sharp CA (2004) Age-related impairment in executive functioning: updating, inhibition, shifting and access. J Clin Exp Neuropsychol 26(7):874–890
Fisk JE, Warr P (1996) Age-related impairment in associative learning: the role of anxiety, arousal and learning self efficacy. Personal Individ Differ 21(5):675–686
Fisk JE, Montgomery C, Murphy P, Wareing M (2004) Evidence for executive deficits among users of MDMA (ecstasy). Br J Psychol 95:457–466
Fox HC, Parrott AC, Turner JJD (2001) Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J Psychopharmacol 15(4):273–281
Green AR, Mechan AO, Elliot JM, O’Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxy-methamphetamine (MDMA, “ecstasy”). Pharmacol Rev 55:463–508
Halpern JH, Pope HG Jr, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D (2004) Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 75:135–147
Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG Jr (2011) Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction 106:777–786
Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J (2001) Prospective memory, everyday cognitive failure and central executive functioning in recreational users of ecstasy. Human Psychopharmacol 16:607–612
Hoshi Y, Tamura M (1993) Dynamic multichannel near-infrared optical imaging of human brain activity. J Appl Physiol 75(4):1842–1846
Izzetoglu K, Bunce S, Onaral B, Pourrezaei K, Chance B (2004) Functional optical brain imaging using near-infrared during cognitive tasks. Int J Human-Comp Interact 17(2):211–227
Jager G, de Win MML, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF (2008) Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an fMRI study. Neuropsychopharmacology 33:247–258
Kiang M, Christensen BK, Streiner DL, Roy C, Patriciu I, Zipursky RB (2013) Association of abnormal semantic processing with delusion-like ideation in frequent cannabis users: an electrophysiological study. Psychopharmacology 225:95–104
Kreplin U, & Fairclough SH. (2013). Activation of the rostromedial prefrontal cortex during the experience of positive emotion in the context of the aesthetic experience: an fNIRS study. Frontiers in Human Neuroscience 7
Leff DR, Elwell CE, Orihuela-Espina F, Atallah L, Delpy DT, Darzi AW, Yang GY (2008) Changes in prefrontal cortical behaviour depend upon familiarity on a bimanual co-ordination task: an fNIRS study. Neuroimage 39(2):805–813
Leff DR, Orihuela-Espina F, Elwell CE, Athanasiou T, Delpy DT, Darzi AW, Yand G-Z (2011) Assessment of the cerebral cortex during motor task behaviours in adults: a systematic review of functional near infrared spectroscopy (fNIRS) studies. Neuroimage 54:2922–2936
Loonstra AS, Tarlow AR, Sellers AH (2001) COWAT metanorms across age, education, and gender. Appl Neuropsychol 8:161–166
McDowell DM, Kleber HD (1994) MDMA: its history and pharmacology. Psychiatr Ann 24(3):127–130
Miyake A, Friedman NP, Emerson MJ, Witzki, Howerter A, Wager TD (2000) The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: a latent variable analysis. Cogn Psychol 41:49–100
Moeller FG, Steinberg JL, Dougherty DM, Narayana PA, Kramer LA, Renshaw PF (2004) Functional MRI study of working memory in MDMA users. Psychopharmacology 177:185–194
Molliver ME, Berger UV, Mamounas LA, Molliver DC, O’Hearn E, Wilson MA (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann N Y Acad Sci 600:640–661
Montgomery C, Fisk JE, Newcombe R, Murphy PN (2005) The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology 182:262–276
Montgomery C, Fisk JE, Wareing M, Murphy P (2007) Self reported sleep quality and cognitive performance in ecstasy users. Human Psychopharmacol 22:537–548
Morgan MJ, McFie L, Fleetwood LH, Robinson JA (2002) Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159:294–303
Parrott AC (2004) Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology 173:234–241
Raj V, Liang HC, Woodward ND, Bauernfeind AL, Lee J, Dietrich MS, Park S, Cowan RL (2010) MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study. J Psychopharmacol 24(2):187–201
Raven J, Raven JC, Court HH (1998) Manual for Raven’s Progressive Matrices and Vocabulary Scales. Oxford Psychologists Press, Oxford
Reneman L, Booij J, Schmand B, van den Brink W, Gunning B (2000a) Memory disturbances in “ecstasy” users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148:322–324
Reneman L, Habraken JBA, Majoie CBL, den Heeten GJ (2000b) MDMA (“ecstasy”) and its association with cerebrovascular accidents: preliminary findings. Am J Neuroradiol 21:1001–1007
Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J (2002) The acute and chronic effects of MDMA (“ecstasy”) on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26(3):387–396
Ricaurte GA, DeLanney LE, Irwin I, Langston JW (1988) Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res 446(1):165–168
Roberts GM, Garavan H (2010) Evidence of increased activation underlysing cognitive control in ecstasy and cannabis users. Neuroimage 52:429–435
Roberts CA, Fairclough SH, Tames F, Fisk JE, Montgomery C (2013) ERP evidence suggests executive dysfunction in ecstasy polydrug users. Psychopharmacology 228(3):375–388
Sakatani K, Chen S, Lichty W, Zuo H, Wang Y-P (1999) Cerebral blood oxygenation changes induced by auditory stimulation in newborn infants measured by near infrared spectroscopy. Early Hum Dev 55(3):229–236
Scholey AB, Owen L, Gates J, Rodgers J, Buchanan T, Ling J, Heffernan T, Swan P, Stough C, Parrott AC (2011) Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating effects of ecstasy on mood and memory. Neuropsychobiology 63:15–21
Steinbrink J, Villringer A, Kempf F, Haux D, Boden S, Obrig H (2006) Illuminating the BOLD signal: combined fMRI-fNIRS studies. Magn Reson Imaging 24(4):495–505
Stuss DT, Alexander MP, Hamer L, Palumbo C, Dempster R, Binns M, Levine B, Izukawa D (1998) The effects of focal anterior and posterior brain lesions on verbal fluency. J Int Neuropsychol Soc 4:265–278
Thurstone L (1938) Primary mental abilities. University of Chicago Press, Chicago
Urban NBL, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M (2012) Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [11C]DASB and [11C]MDL 100907. Neuropsychopharmacology 37:1465–1473
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roberts, C.A., Montgomery, C. fNIRS suggests increased effort during executive access in ecstasy polydrug users. Psychopharmacology 232, 1571–1582 (2015). https://doi.org/10.1007/s00213-014-3795-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-014-3795-8